{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T14:04:51Z","timestamp":1771337091875,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:00:00Z","timestamp":1524441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:00:00Z","timestamp":1524441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["CP14\/00010"],"award-info":[{"award-number":["CP14\/00010"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI15\/00473 and RD12\/0014\/0007"],"award-info":[{"award-number":["PI15\/00473 and RD12\/0014\/0007"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CM14\/00096"],"award-info":[{"award-number":["CM14\/00096"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD16\/0019\/0018"],"award-info":[{"award-number":["RD16\/0019\/0018"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014180","name":"Junta de Castilla y Le\u00f3n","doi-asserted-by":"crossref","award":["BIO\/SA35\/15"],"award-info":[{"award-number":["BIO\/SA35\/15"]}],"id":[{"id":"10.13039\/501100014180","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003176","name":"Ministerio de Educaci\u00f3n, Cultura y Deporte","doi-asserted-by":"publisher","award":["FPU program"],"award-info":[{"award-number":["FPU program"]}],"id":[{"id":"10.13039\/501100003176","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2019,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cerebral preconditioning (PC) confers endogenous brain protection after stroke. Ischemic stroke patients with a prior transient ischemic attack (TIA) may potentially be in a preconditioned state. Although PC has been associated with the activation of pro-survival signals, the mechanism by which preconditioning confers neuroprotection is not yet fully clarified. Recently, we have described that PC-mediated neuroprotection against ischemic insult is promoted by p53 destabilization, which is mediated by its main regulator MDM2. Moreover, we have previously described that the human\n                    <jats:italic>Tp53 Arg72Pro<\/jats:italic>\n                    single nucleotide polymorphism (SNP) controls susceptibility to ischemia-induced neuronal apoptosis and governs the functional outcome of patients after stroke. Here, we studied the contribution of the human\n                    <jats:italic>Tp53 Arg72Pro<\/jats:italic>\n                    SNP on PC-induced neuroprotection after ischemia. Our results showed that cortical neurons expressing the Pro72-p53 variant exhibited higher PC-mediated neuroprotection as compared with Arg72-p53 neurons. PC prevented ischemia-induced nuclear and cytosolic p53 stabilization in Pro72-p53 neurons. However, PC failed to prevent mitochondrial p53 stabilization, which occurs in Arg72-p53 neurons after ischemia. Furthermore, PC promoted neuroprotection against ischemia by controlling the p53\/active caspase-3 pathway in Pro72-p53, but not in Arg72-p53 neurons. Finally, we found that good prognosis associated to TIA within 1\u00a0month prior to ischemic stroke was restricted to patients harboring the Pro72 allele. Our findings demonstrate that the\n                    <jats:italic>Tp53 Arg72Pro<\/jats:italic>\n                    SNP controls PC-promoted neuroprotection against a subsequent ischemic insult by modulating mitochondrial p53 stabilization and then modulates TIA-induced ischemic tolerance.\n                  <\/jats:p>","DOI":"10.1007\/s12975-018-0631-1","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T06:30:12Z","timestamp":1524465012000},"page":"204-215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The Neuronal Ischemic Tolerance Is Conditioned by the Tp53 Arg72Pro Polymorphism"],"prefix":"10.1007","volume":"10","author":[{"given":"Maria E.","family":"Ramos-Araque","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebeca","family":"Vecino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Cortijo Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"de Lera Alfonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Sanchez Barba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Col\u00e0s-Camp\u00e0s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Purroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan F.","family":"Arenillas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angeles","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6205-6611","authenticated-orcid":false,"given":"Maria","family":"Delgado-Esteban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,23]]},"reference":[{"issue":"1","key":"631_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/WCO.0b013e32835bf200","volume":"26","author":"SV Narayanan","year":"2013","unstructured":"Narayanan SV, Dave KR, Perez-Pinzon MA. Ischemic preconditioning and clinical scenarios. Curr Opin Neurol. 2013;26(1):1\u20137.","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"631_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12975-009-0007-7","volume":"1","author":"RF Keep","year":"2010","unstructured":"Keep RF, Wang MM, Xiang J, Hua Y, Xi G. Is there a place for cerebral preconditioning in the clinic? Transl Stroke Res. 2010;1(1):4\u201318.","journal-title":"Transl Stroke Res"},{"key":"631_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.pneurobio.2013.11.005","volume":"114","author":"RA Stetler","year":"2014","unstructured":"Stetler RA, Leak RK, Gan Y, Li P, Zhang F, Hu X, et al. Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance. Prog Neurobiol. 2014;114:58\u201383.","journal-title":"Prog Neurobiol"},{"issue":"9958","key":"631_CR4","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","volume":"384","author":"J Emberson","year":"2014","unstructured":"Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014;384(9958):1929\u201335.","journal-title":"Lancet"},{"issue":"11","key":"631_CR5","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1212\/WNL.55.11.1649","volume":"55","author":"JR Marler","year":"2000","unstructured":"Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC, et al. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology. 2000;55(11):1649\u201355.","journal-title":"Neurology"},{"issue":"5","key":"631_CR6","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.5114\/aoms.2016.63744","volume":"13","author":"WW Wang","year":"2017","unstructured":"Wang WW, et al. Prior transient ischemic attacks may have a neuroprotective effect in patients with ischemic stroke. Arch Med Sci. 2017;13(5):1057\u201361.","journal-title":"Arch Med Sci"},{"issue":"9","key":"631_CR7","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1161\/01.STR.30.9.1851","volume":"30","author":"M Weih","year":"1999","unstructured":"Weih M, Kallenberg K, Bergk A, Dirnagl U, Harms L, Wernecke KD, et al. Attenuated stroke severity after prodromal TIA: a role for ischemic tolerance in the brain? Stroke. 1999;30(9):1851\u20134.","journal-title":"Stroke"},{"issue":"11","key":"631_CR8","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1212\/WNL.54.11.2089","volume":"54","author":"J Moncayo","year":"2000","unstructured":"Moncayo J, de Freitas GR, Bogousslavsky J, Altieri M, van Melle G. Do transient ischemic attacks have a neuroprotective effect? Neurology. 2000;54(11):2089\u201394.","journal-title":"Neurology"},{"issue":"3","key":"631_CR9","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1161\/01.STR.0000115767.17923.6A","volume":"35","author":"S Wegener","year":"2004","unstructured":"Wegener S, Gottschalk B, Jovanovic V, Knab R, Fiebach JB, Schellinger PD, et al. Transient ischemic attacks before ischemic stroke: preconditioning the human brain? A multicenter magnetic resonance imaging study. Stroke. 2004;35(3):616\u201321.","journal-title":"Stroke"},{"issue":"9","key":"631_CR10","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1136\/jnnp.2010.209171","volume":"82","author":"C Aboa-Eboule","year":"2011","unstructured":"Aboa-Eboule C, Bejot Y, Osseby GV, Rouaud O, Binquet C, Marie C, et al. Influence of prior transient ischaemic attack on stroke prognosis. J Neurol Neurosurg Psychiatry. 2011;82(9):993\u20131000.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"631_CR11","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/jnr.20674","volume":"82","author":"KR Dave","year":"2005","unstructured":"Dave KR, Lange-Asschenfeldt C, Raval AP, Prado R, Busto R, Saul I, et al. Ischemic preconditioning ameliorates excitotoxicity by shifting glutamate\/gamma-aminobutyric acid release and biosynthesis. J Neurosci Res. 2005;82(5):665\u201373.","journal-title":"J Neurosci Res"},{"issue":"2","key":"631_CR12","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1046\/j.1471-4159.2000.0750812.x","volume":"75","author":"AG Douen","year":"2000","unstructured":"Douen AG, Akiyama K, Hogan MJ, Wang F, Dong L, Chow AK, et al. Preconditioning with cortical spreading depression decreases intraischemic cerebral glutamate levels and down-regulates excitatory amino acid transporters EAAT1 and EAAT2 from rat cerebal cortex plasma membranes. J Neurochem. 2000;75(2):812\u20138.","journal-title":"J Neurochem"},{"issue":"2","key":"631_CR13","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/jcbfm.2008.126","volume":"29","author":"RA DeFazio","year":"2009","unstructured":"DeFazio RA, Raval AP, Lin HW, Dave KR, Della-Morte D, Perez-Pinzon MA. GABA synapses mediate neuroprotection after ischemic and epsilonPKC preconditioning in rat hippocampal slice cultures. J Cereb Blood Flow Metab. 2009;29(2):375\u201384.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"631_CR14","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1161\/01.STR.0000016404.14407.77","volume":"33","author":"C Sommer","year":"2002","unstructured":"Sommer C, Fahrner A, Kiessling M. [3H]muscimol binding to gamma-aminobutyric acid(A) receptors is upregulated in CA1 neurons of the gerbil hippocampus in the ischemia-tolerant state. Stroke. 2002;33(6):1698\u2013705.","journal-title":"Stroke"},{"issue":"2","key":"631_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1750-3639.1995.tb00587.x","volume":"5","author":"C Sommer","year":"1995","unstructured":"Sommer C, Gass P, Kiessling M. Selective c-JUN expression in CA1 neurons of the gerbil hippocampus during and after acquisition of an ischemia-tolerant state. Brain Pathol. 1995;5(2):135\u201344.","journal-title":"Brain Pathol"},{"issue":"5","key":"631_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0166-2236(03)00071-7","volume":"26","author":"U Dirnagl","year":"2003","unstructured":"Dirnagl U, Simon RP, Hallenbeck JM. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci. 2003;26(5):248\u201354.","journal-title":"Trends Neurosci"},{"issue":"11","key":"631_CR17","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s00415-002-0933-8","volume":"249","author":"B Schaller","year":"2002","unstructured":"Schaller B, Graf R. Cerebral ischemic preconditioning. An experimental phenomenon or a clinical important entity of stroke prevention? J Neurol. 2002;249(11):1503\u201311.","journal-title":"J Neurol"},{"issue":"9","key":"631_CR18","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1161\/01.STR.29.9.1937","volume":"29","author":"FC Barone","year":"1998","unstructured":"Barone FC, et al. Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke. 1998;29(9):1937\u201350. discussion 1950\u20131","journal-title":"Stroke"},{"issue":"2","key":"631_CR19","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S0169-328X(99)00146-1","volume":"70","author":"G Tomasevic","year":"1999","unstructured":"Tomasevic G, Shamloo M, Israeli D, Wieloch T. Activation of p53 and its target genes p21(WAF1\/Cip1) and PAG608\/Wig-1 in ischemic preconditioning. Brain Res Mol Brain Res. 1999;70(2):304\u201313.","journal-title":"Brain Res Mol Brain Res"},{"issue":"8","key":"631_CR20","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.bbadis.2013.12.015","volume":"1842","author":"DB Wang","year":"2014","unstructured":"Wang DB, et al. p53 and mitochondrial function in neurons. Biochim Biophys Acta. 2014;1842(8):1186\u201397.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"631_CR21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1023\/A:1025365432325","volume":"23","author":"JE Chipuk","year":"2003","unstructured":"Chipuk JE, Green DR. p53\u2019s believe it or not: lessons on transcription-independent death. J Clin Immunol. 2003;23(5):355\u201361.","journal-title":"J Clin Immunol"},{"issue":"3","key":"631_CR22","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1084\/jem.20101523","volume":"208","author":"JC Gomez-Sanchez","year":"2011","unstructured":"Gomez-Sanchez JC, Delgado-Esteban M, Rodriguez-Hernandez I, Sobrino T, Perez de la Ossa N, Reverte S, et al. The human Tp53 Arg72Pro polymorphism explains different functional prognosis in stroke. J Exp Med. 2011;208(3):429\u201337.","journal-title":"J Exp Med"},{"issue":"3","key":"631_CR23","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.bbrc.2005.03.187","volume":"331","author":"S Erster","year":"2005","unstructured":"Erster S, Moll UM. Stress-induced p53 runs a transcription-independent death program. Biochem Biophys Res Commun. 2005;331(3):843\u201350.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"631_CR24","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.tig.2005.01.001","volume":"21","author":"M Schuler","year":"2005","unstructured":"Schuler M, Green DR. Transcription, apoptosis and p53: catch-22. Trends Genet. 2005;21(3):182\u20137.","journal-title":"Trends Genet"},{"issue":"5","key":"631_CR25","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/ncb1123","volume":"6","author":"JI Leu","year":"2004","unstructured":"Leu JI, et al. Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol. 2004;6(5):443\u201350.","journal-title":"Nat Cell Biol"},{"issue":"12","key":"631_CR26","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.4161\/cc.3.12.1318","volume":"3","author":"S Erster","year":"2004","unstructured":"Erster S, Moll UM. Stress-induced p53 runs a direct mitochondrial death program: its role in physiologic and pathophysiologic stress responses in vivo. Cell Cycle. 2004;3(12):1492\u20135.","journal-title":"Cell Cycle"},{"issue":"2","key":"631_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1385\/JMN:24:2:299","volume":"24","author":"HC Zhu","year":"2004","unstructured":"Zhu HC, Gao XQ, Xing Y, Sun SG, Li HG, Wang YF. Inhibition of caspase-3 activation and apoptosis is involved in 3-nitropropionic acid-induced ischemic tolerance to transient focal cerebral ischemia in rats. J Mol Neurosci. 2004;24(2):299\u2013305.","journal-title":"J Mol Neurosci"},{"issue":"1","key":"631_CR28","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/jnr.20869","volume":"84","author":"A Hoshi","year":"2006","unstructured":"Hoshi A, Nakahara T, Kayama H, Yamamoto T. Ischemic tolerance in chemical preconditioning: possible role of astrocytic glutamine synthetase buffering glutamate-mediated neurotoxicity. J Neurosci Res. 2006;84(1):130\u201341.","journal-title":"J Neurosci Res"},{"issue":"1","key":"631_CR29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/jnr.20232","volume":"78","author":"J Pera","year":"2004","unstructured":"Pera J, Zawadzka M, Kaminska B, Szczudlik A. Influence of chemical and ischemic preconditioning on cytokine expression after focal brain ischemia. J Neurosci Res. 2004;78(1):132\u201340.","journal-title":"J Neurosci Res"},{"issue":"1","key":"631_CR30","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/s41598-018-19921-x","volume":"8","author":"R Vecino","year":"2018","unstructured":"Vecino R, Burguete MC, Jover-Mengual T, Agulla J, Bobo-Jim\u00e9nez V, Salom JB, et al. The MDM2-p53 pathway is involved in preconditioning-induced neuronal tolerance to ischemia. Sci Rep. 2018;8(1):1610.","journal-title":"Sci Rep"},{"issue":"1","key":"631_CR31","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/cdd.2016.109","volume":"24","author":"C Rodriguez","year":"2017","unstructured":"Rodriguez C, et al. Neovascularization and functional recovery after intracerebral hemorrhage is conditioned by the Tp53 Arg72Pro single-nucleotide polymorphism. Cell Death Differ. 2017;24(1):144\u201354.","journal-title":"Cell Death Differ"},{"issue":"14","key":"631_CR32","doi-asserted-by":"publisher","first-page":"5851","DOI":"10.1158\/0008-5472.CAN-09-4646","volume":"70","author":"F Zhu","year":"2010","unstructured":"Zhu F, Dolle MET, Berton TR, Kuiper RV, Capps C, Espejo A, et al. Mouse models for the p53 R72P polymorphism mimic human phenotypes. Cancer Res. 2010;70(14):5851\u20139.","journal-title":"Cancer Res"},{"issue":"2","key":"631_CR33","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1046\/j.1471-4159.2002.00827.x","volume":"81","author":"A Almeida","year":"2002","unstructured":"Almeida A, Delgado-Esteban M, Bola\u00f1os JP, Medina JM. Oxygen and glucose deprivation induces mitochondrial dysfunction and oxidative stress in neurones but not in astrocytes in primary culture. J Neurochem. 2002;81(2):207\u201317.","journal-title":"J Neurochem"},{"issue":"17","key":"631_CR34","doi-asserted-by":"publisher","first-page":"6608","DOI":"10.1523\/JNEUROSCI.21-17-06608.2001","volume":"21","author":"SA Reichert","year":"2001","unstructured":"Reichert SA, Kim-Han JS, Dugan LL. The mitochondrial permeability transition pore and nitric oxide synthase mediate early mitochondrial depolarization in astrocytes during oxygen-glucose deprivation. J Neurosci. 2001;21(17):6608\u201316.","journal-title":"J Neurosci"},{"issue":"6","key":"631_CR35","first-page":"430","volume":"5","author":"L Celso Constantino","year":"2014","unstructured":"Celso Constantino L, Tasca CI, Boeck CR. The role of NMDA receptors in the development of brain resistance through pre- and post-conditioning. Aging Dis. 2014;5(6):430\u201341.","journal-title":"Aging Dis"},{"issue":"17","key":"631_CR36","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1523\/JNEUROSCI.0455-06.2006","volume":"26","author":"FX Soriano","year":"2006","unstructured":"Soriano FX, Papadia S, Hofmann F, Hardingham NR, Bading H, Hardingham GE. Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability. J Neurosci. 2006;26(17):4509\u201318.","journal-title":"J Neurosci"},{"issue":"20","key":"631_CR37","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1038\/emboj.2008.195","volume":"27","author":"C Maestre","year":"2008","unstructured":"Maestre C, Delgado-Esteban M, Gomez-Sanchez JC, Bola\u00f1os JP, Almeida A. Cdk5 phosphorylates Cdh1 and modulates cyclin B1 stability in excitotoxicity. EMBO J. 2008;27(20):2736\u201345.","journal-title":"EMBO J"},{"issue":"3","key":"631_CR38","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1385-299X(97)00044-5","volume":"2","author":"A Almeida","year":"1998","unstructured":"Almeida A, Medina JM. A rapid method for the isolation of metabolically active mitochondria from rat neurons and astrocytes in primary culture. Brain Res Brain Res Protoc. 1998;2(3):209\u201314.","journal-title":"Brain Res Brain Res Protoc"},{"key":"631_CR39","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1038\/ncomms3879","volume":"4","author":"M Delgado-Esteban","year":"2013","unstructured":"Delgado-Esteban M, et al. APC\/C-Cdh1 coordinates neurogenesis and cortical size during development. Nat Commun. 2013;4:2879.","journal-title":"Nat Commun"},{"issue":"6","key":"631_CR40","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1161\/STROKEAHA.108.192218","volume":"40","author":"JD Easton","year":"2009","unstructured":"Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E, et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association\/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke. 2009;40(6):2276\u201393.","journal-title":"Stroke"},{"issue":"2","key":"631_CR41","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.nrl.2011.09.012","volume":"29","author":"M Alonso de Lecinana","year":"2014","unstructured":"Alonso de Lecinana M, et al. Guidelines for the treatment of acute ischaemic stroke. Neurologia. 2014;29(2):102\u201322.","journal-title":"Neurologia"},{"issue":"1","key":"631_CR42","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35\u201341.","journal-title":"Stroke"},{"issue":"3","key":"631_CR43","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1161\/01.STR.0000258355.23810.c6","volume":"38","author":"JL Banks","year":"2007","unstructured":"Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke. 2007;38(3):1091\u20136.","journal-title":"Stroke"},{"issue":"Pt 6","key":"631_CR44","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1042\/bst0290684","volume":"29","author":"M Schuler","year":"2001","unstructured":"Schuler M, Green DR. Mechanisms of p53-dependent apoptosis. Biochem Soc Trans. 2001;29(Pt 6):684\u20138.","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"631_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-3835(01)00698-X","volume":"174","author":"O Pluquet","year":"2001","unstructured":"Pluquet O, Hainaut P. Genotoxic and non-genotoxic pathways of p53 induction. Cancer Lett. 2001;174(1):1\u201315.","journal-title":"Cancer Lett"},{"issue":"3","key":"631_CR46","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/00004647-199803000-00002","volume":"18","author":"M Endres","year":"1998","unstructured":"Endres M, Namura S, Shimizu-Sasamata M, Waeber C, Zhang L, G\u00f3mez-Isla T, et al. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J Cereb Blood Flow Metab. 1998;18(3):238\u201347.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"631_CR47","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00018-012-1029-y","volume":"70","author":"A Almeida","year":"2013","unstructured":"Almeida A. Genetic determinants of neuronal vulnerability to apoptosis. Cell Mol Life Sci. 2013;70(1):71\u201388.","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"631_CR48","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1161\/01.STR.28.5.1073","volume":"28","author":"JA Clemens","year":"1997","unstructured":"Clemens JA, et al. Global ischemia activates nuclear factor-kappa B in forebrain neurons of rats. Stroke. 1997;28(5):1073\u201380. discussion 1080-1","journal-title":"Stroke"},{"issue":"3\u20134","key":"631_CR49","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1177\/1947601912455199","volume":"3","author":"D Shi","year":"2012","unstructured":"Shi D, Gu W. Dual roles of MDM2 in the regulation of p53: ubiquitination dependent and ubiquitination independent mechanisms of MDM2 repression of p53 activity. Genes Cancer. 2012;3(3\u20134):240\u20138.","journal-title":"Genes Cancer"},{"issue":"21","key":"631_CR50","doi-asserted-by":"publisher","first-page":"16202","DOI":"10.1074\/jbc.275.21.16202","volume":"275","author":"ND Marchenko","year":"2000","unstructured":"Marchenko ND, Zaika A, Moll UM. Death signal-induced localization of p53 protein to mitochondria A potential role in apoptotic signaling. J Biol Chem. 2000;275(21):16202\u201312.","journal-title":"J Biol Chem"},{"issue":"3","key":"631_CR51","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0014-5793(00)02368-1","volume":"488","author":"C Sansome","year":"2001","unstructured":"Sansome C, Zaika A, Marchenko ND, Moll UM. Hypoxia death stimulus induces translocation of p53 protein to mitochondria Detection by immunofluorescence on whole cells. FEBS Lett. 2001;488(3):110\u20135.","journal-title":"FEBS Lett"},{"issue":"3","key":"631_CR52","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.nbd.2008.12.010","volume":"33","author":"C Chen","year":"2009","unstructured":"Chen C, Hu Q, Yan J, Yang X, Shi X, Lei J, et al. Early inhibition of HIF-1alpha with small interfering RNA reduces ischemic-reperfused brain injury in rats. Neurobiol Dis. 2009;33(3):509\u201317.","journal-title":"Neurobiol Dis"}],"updated-by":[{"DOI":"10.1007\/s12975-026-01417-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000}}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-018-0631-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12975-018-0631-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-018-0631-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T13:02:05Z","timestamp":1771333325000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12975-018-0631-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,23]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4,15]]}},"alternative-id":["631"],"URL":"https:\/\/doi.org\/10.1007\/s12975-018-0631-1","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,23]]},"assertion":[{"value":"6 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12975-026-01417-w","URL":"https:\/\/doi.org\/10.1007\/s12975-026-01417-w","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Animals were maintained in specific-pathogen free facilities at the University of Salamanca, in accordance with Spanish legislation (RD53\/2013) under license from the Spanish government and the EU (2010\/63\/EU). Protocols were approved by the Bioethics Committees of the University of Salamanca.All procedures performed in studies involving human participants were approved by the local ethics committees and were in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}